Kaplan-Meier graphs for breast cancer incidence in the tamoxifen

Third Symposium on Primary Breast Cancer in Older Women

Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion

Kaplan-Meier graphs for breast cancer incidence in the tamoxifen arm

Relationship Between Molecular Subtypes and Overall Survival of Breast Cancer in Bandung – Biomedical and Pharmacology Journal

2021 Update on Systemic Therapy for Breast Cancer Published in healthbook TIMES Oncology Hematology

Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours

Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients

Ivana SESTAK, Associate Professor in Medical Statistics

A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy

Frontiers Breast Cancer Survival in Eastern Region of Ghana

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial - The Lancet Oncology

Fig A1. Kaplan-Meier distribution and recurrence rates for

The fluctuating incidence, improved survival of patients with breast c

Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot, BMC Cancer